Ownership history in Orbis Allan Gray Ltd Β· 40 quarters on record
This page tracks every 13F SEC filing in which Orbis Allan Gray Ltd reported a position in NETEASE INC (NTES). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β sourced directly from SEC EDGAR 13F filings.
π Orbis Allan Gray Ltd outperformed the S&P 500 by +7.3% annually on this NTES position. Timing score: 36% (14/39 decisions correct). Average cost basis: $62.33. Maximum drawdown during holding period: β35.5%.
π₯ Exceptional β beat the S&P 500 by 7.3% per year on this position.
39 quarters analyzed
β οΈ Poor timing β buys often preceded drops, trims preceded rallies.
14 of 39 add/trim decisions correct
Best entry: $23.99 (2016 Q1) Β· Worst: $149.88 (2025 Q3)
πͺ Held through 2 major drawdowns (>20%).
18 adds Β· 22 trims. Bought during 8 of 14 down-price quarters. π Predominantly trimming β distribution phase.
π Orbis Allan Gray Ltd has been actively increasing its NTES allocation β a bullish signal from insiders.
Currently 1.95% of portfolio
β Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ 4 (annualised). Not investment advice.
As of 2025 Q4 β sorted by position size